RPL23AP71

Across TCGA pan-cancer cohorts, RPL23AP71 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RPL23AP71 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL23AP71 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL23AP71 expression acts as an unfavorable survival marker, although some lineages such as CESC and ESCA show a favorable association.

KIRC, CHOL, and OV are the cancer types where RPL23AP71 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	All	0.514	0.665	<.001	93	view →
CHOL	OS	Tertile	All	0.120	0.767	<.001	63	view →
OV	OS	Median	All	0.795	0.885	.001	44	view →
CESC	OS	Tertile	All	0.955	0.850	.014	30	view →
ESCA	OS	Quartile	III,IV	0.737	0.354	.002	29	view →
THCA	DFS	Tertile	IV	0.637	0.964	.011	18	view →
LUSC	OS	Tertile	III,IV	0.159	0.659	.009	17	view →
BLCA	DFS	Tertile	IV	0.103	0.242	.028	15	view →
THYM	DFS	Tertile	All	1.000	0.493	.003	12	view →
COAD	OS	Tertile	All	0.958	0.840	.010	9	view →
PAAD	DFS	Tertile	All	0.362	0.504	.038	9	view →
MESO	OS	Tertile	III,IV	0.247	0.573	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RPL23AP71–KIRC (OS)

Open the KIRC breakdown →